Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KMON: Lopinavir/Ritonavir Once Daily Monotherapy Switch
NCT01581853Phase 4Completed
- Start
- May 2012
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lopinavir + ritonavir in human immunodeficiency virus infection (HIV). Started May 2012; status: completed.
02
Drugs
lopinavir + ritonavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01581853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01581853.